Biomedicine Hub (Apr 2021)

Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report

  • Alejandro Martín-Quirós,
  • Charbel Maroun-Eid,
  • José Avendaño-Ortiz,
  • Roberto Lozano-Rodríguez,
  • Jaime Valentín Quiroga,
  • Verónica Terrón,
  • Karla Montalbán-Hernández,
  • Miguel A. García-Garrido,
  • Elena Muñoz del Val,
  • Álvaro del Balzo-Castillo,
  • Carolina Rubio,
  • Carolina Cubillos-Zapata,
  • Luis A. Aguirre,
  • Eduardo López-Collazo

DOI
https://doi.org/10.1159/000514727
Journal volume & issue
Vol. 6, no. 1
pp. 48 – 58

Abstract

Read online

We report the disparate clinical progression of a couple infected by SARS-CoV-2 based on their immune checkpoint (IC) levels and immune cell distribution in blood from admission to exitus in patient 1 and from admission to discharge and recovery in patient 2. A detailed clinical follow-up accompanied by a longitudinal analysis of immune phenotypes and IC levels is shown. The continuous increase in the soluble IC ligand galectin-9 (Gal-9) and the increment in T-cell immunoglobulin and mucin domain-containing 3 (TIM-3) protein in T cells in patient 1 suggests an activation of the Gal-9/TIM-3 axis and, subsequently, a potential cell exhaustion in this patient that did not occur in patient 2. Our data indicate that the Gal-9/TIM-3 axis could be a potential target in this clinical setting, along with a patent effector memory T-cell reduction.

Keywords